Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
Introduction Drug-resistant tuberculosis (TB) remains a global health threat, with little over 50% of patients successfully treated. Novel regimens like the ones being studied in the TB-PRACTECAL trial are urgently needed. Understanding anti-TB drug exposures could explain the success or failure of...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2021-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/9/e047185.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens.
by: Dzintars Gotham, et al.
Published: (2025-01-01) -
Population pharmacokinetics and pharmacodynamics of two dosing regimens of antenatal corticosteroids: protocol for a prospective nested study in a randomised controlled trial
by: Adejumoke Idowu Ayede, et al.
Published: (2025-06-01) -
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial
by: Roisin Connon, et al.
Published: (2024-11-01) -
Accuracy and consequences of using trial-of-antibiotics for TB diagnosis (ACT-TB study): protocol for a randomised controlled clinical trial
by: Neil French, et al.
Published: (2020-03-01) -
Editorial: Application of PKPD modeling in drug discovery and development
by: Hong-Can Ren, et al.
Published: (2025-06-01)